Lucira™ COVID-19 & Flu Combo Rapid Molecular Point-of-Care (POC) Test (Case of 24 Test Kits - 1 Test/Box)

The Lucira™ COVID-19 & Flu Combo rapid molecular point-of-care (POC) test is intended for the qualitative detection of Covid-19, Influenza A, and Influenza B.  Results in as fast as 11 minutes for a positive result, 30 Minutes for a negative result Correctly identifies: 98.2% of positive specimens for COVID-19 100.0% of positive specimens for Influenza A 97.6% of positive specimens for Influenza B Correctly identifies 100.0% of negative specimens for COVID-19 99.7% of negative specimens for Influenza A 99.5% of negative specimens for Influenza B Not authorized for unsupervised self-collection in home or office No calibration, controls, or training required No instruments, reader, plug, or connectivity For use with or without symptoms Simple nasal swab collection process Suitable for children 2 years or older SHS SKU 8-10055-97013-1 Manufacturer Number UPC Brand COVID-19 & Flu Test Manufacturer Lucira™ Country of Origin U.S. Application Rapid Molec